StemCell Therapy

Dr. Donald Moss

MONTREAL (PRWEB) May 26, 2020

In an ongoing webinar series presented by Thought Technology Ltd., experts from various fields discuss how they are using biofeedback in their practices. Todays mental health practitioners have many tools at their disposal to best address the individual needs of their clients. In an upcoming webinar, Dr. Donald Moss will discuss adjunctive therapies that can be used in conjunction with biofeedback.

Adjunctive therapies are interventions that combine well with biofeedback and neurofeedback training and augment the therapeutic effect of the biofeedback and neurofeedback. The combined therapeutic effect of biofeedback and relaxation together is often greater than the effect of either intervention alone. Regular home practice of relaxation skills improves basal autonomic nervous system regulation and reduces the onset of problematic symptoms. This Webinar introduces six adjunctive therapies, including progressive muscle relaxation, autogenic training, paced diaphragmatic breathing, guided imagery, meditation, and mindfulness. Two of them will be demonstrated, and brief clinical vignettes will illustrate the use of the adjunctive techniques. Each of these skill sets can be administered on its own, with therapeutic effect, or provided in combination with biofeedback as a treatment package.

Adjunctive Therapies for Use with Biofeedback and NeurofeedbackPresenter: Dr. Donald MossDate: May 29, 2020Time: 1:00-2:00 pm EDT

Click here to register.

About Dr. Donald MossDonald Moss, Ph.D., BCB, is Dean, College of Integrative Medicine and Health Sciences, at Saybrook University, Oakland, CA. Dr. Moss is the Education Chair of the Society for Clinical and Experimental Hypnosis (SCEH). He is also the ethics chair and international certification chair for the Biofeedback Certification International Alliance. He has served as president of Division 30 (hypnosis) of the American Psychological Association, SCEH, and the Association for Applied Psychophysiology and Biofeedback (AAPB). Dr. Moss has a book with co-author Angele McGrady on Integrative Pathways: Navigating Chronic Illness with a Mind-Body-Spirit Approach (Springer, 2018), and a book with co-editor Fredric Shaffer on Physiological Recording Technology and Applications in Biofeedback and Neurofeedback (AAPB, 2019). He has a book in press with co-editor Inna Khazan on Mindfulness, Compassion, and Biofeedback Practice (AAPB). Moss is co-editor of Foundations of Heart Rate Variability Biofeedback (AAPB, 2016), co-author of Pathways to Illness, Pathways to Health (Springer, 2013), and chief editor of Handbook of Mind-Body Medicine for Primary Care (Sage, 2003) and Humanistic and Transpersonal Psychology (Greenwood, 1998).

About Thought Technology Ltd.Founded in 1975, Thought Technology is the world's leading biofeedback and physiological instrument manufacturer. Its products are used as an essential part of many therapeutic treatments and clinical assessment protocols in over 85 countries and are used by tens of thousands of clinicians in thousands of medical institutions.

Always supportive of new research and development ideas, Thought Technology Ltd. has encouraged a number of special interest groups and clinicians to create cutting edge applications for its instrumentation. Thought Technology Ltd. equipment is now being used in telemedicine, web-based monitoring and biofeedback, sports training, research in human-machine interface, physiology-driven multimedia environments and virtual reality. Constantly striving to improve the quality of the products and services, TTL has obtained, and maintains, ISO 13485, and CE certification for the organization and products.

Share article on social media or email:

Read this article:
Thought Technology's Webinar Series Focuses on Adjunctive Therapies That Combine Well with Biofeedback and Neurofeedback - PR Web

This entry was posted on May 27, 2020 at 12:20 pm and is filed under Integrative Medicine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |